1. Terminology and guidelines for glaucoma. European glaucoma society, 4^th ed. 2014 - 192 p.

2. Национальное руководство по глаукоме. Руководство для практикующих врачей, изд. 4-е. М., ГЭОТАР-Медиа. - 2019 - 384 с.

3. World Glaucoma Association Consensus Statement: Angle Closure and Angle Closure Glaucoma/Weinreb RN, Friedman DS, eds.//The Netherlands: Kluger. - 2006 - 113 p.

4. Primary Angle Closure/American Academy of Ophthalmology Preferred Practice Pattern(R) Guidelines, San Francisco. 2015 - 40 p.

5. Shaarawy T.M., Sherwood M.B., Hitchimgs R.A., Crowston J.G. Glaucoma: medical diagnosis and therapy, 2-nd (Vol. 1). London: Elsevir, 2015: 1201

6. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia/Foster PJ, Baasanhu J, Alsbirk PH, et al.//Arch Ophthalmol. - 1996 - Vol. 114. - P. 1235 - 41.

7. The prevalence of glaucoma/Bengtsson B.//Br J Ophthalmol. - 1981 - Vol. 65. - P. 46 - 9.

8. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study/Wolfs RC, Grobbee DE, Hofman A, de Jong PT.//Invest Ophthalmol Vis Sci. - 1997 - Vol. 38. - P. 2683 - 7.

9. Issues in the Epidemiology and Population-Based Screening of Primary Angle-Closure Glaucoma/Congdon N., Wang F., Tielsch J.M.//Surv Ophthalmol. - 1992 - Vol. 36. - P. 411 - 423.

10. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study/Lai JS, Liu DT, Tham CC, et al.//Hong Kong Med J. - 2001 - Vol. 7. - P. 118 - 23.

11. Family studies in glaucoma/Perkins ES.//Br J Ophthalmol. - 1974 - Vol. 58. - P. 529 - 35.

12. Survey of the first-degree relatives of glaucoma patients/Leighton DA.//Trans Ophthalmol Soc UK. - 1976 - Vol. 96. - P. 28 - 32.

13. Злокачественная глаукома: диагностика, клиника, лечение/Ефимова М.Н.//Глаукома. 2002 - N 1 - С. 53 - 60.

14. Possible mechanisms of primary angle-closure and malignant glaucoma./Quigley HA, Friedman DS, Congdon NG.//J Glaucoma 2003 - Vol. 12. - N 2. - P. 167 - 180.

15. Nanophthalmic sclera; morphologic and tissue culture studiem./Yue BYJT, Duvall J, Goldberg MF, Puck A, Tso MO, Sugar//J. Ophtalmology. - 1986 - Vol 93. - P. 534 - 541.

16. Global data on visual impairment in the year 2002./Resnikoff S., Pascolini D., Etyaale D., Kocur I., Pararajasegaram P., Pjkharel G.P. et al.//WHO Bull. - 2004. - Vol. 82. - P. 844 - 855.

17. The number of persons with glaucoma worldwide in 2010 and 2020./Quigley HA, Broman AT.//Br J Ophthalmol. 2006. - Vol. 90. - P. 262 - 267.

18. Angle closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study./Dandona L., Dandona R., Mandal P., Srinivas M., John R.K., McCarty C.A., et al.//Ophthalmology. - 2000 - Vol. 107. - P. 1710 - 1716.

19. Prevalence of primary glaucoma in an urban south Indian population./Jacob A., Thomas R., Koshi S.P., Braganza A., Muliyil J.//Ind J Ophthalmol. - 1998. - Vol. 46. - P. 81 - 86.

20. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey./Ramakrishnan R., Nirmalan P.K., Krishnadas R., Thulasiraj R.D., Tielsch J.M., Katz J., et al.//Ophthalmology. - 2003 - Vol. 110. - P. 1484 - 1490.

21. Prevalence of angle-closure disease in a rural southern Indian population./Vijaya L., George R., Arvind H., Baskaran M., Paul P.G., Ramesh S.V., et al.//Arch Ophthalmol. - 2006 - Vol. 124. - P. 403 - 409.

22. Epidemiology of glaucoma in Japan - A nationwide glaucoma survey./Shiose Y., Kitazawa Y., Tsukuhara S., Akamatsu T., Mizokami K., Futa R., et al.//Jpn J Ophthalmol. - 1991. - Vol. 35. - P. 133 - 135.

23. Glaucoma in Mongolia - A poplation-based survey in Hovsgol Province, Northern Mongolia./Foster P.J., Baasanhu J., Alsbrik P.H., Munkhbayar D., Uranchimeg D., Jonson G.J.//Arc Ophthalmol. - 1996 - Vol. 114. - P. 1235 - 1241.

24. The prevalence of glaucoma in Chinese residents of Singapure. A cross-sectional population survey in Tanjong Pagar district./Foster P.J., Oen F.T., Machin D.S., Ng T.P., Devereux J.G., Jonson G.J., et al.//Arc Ophthalmol. - 2000 - Vol. 118. - P. 1105 - 1111.

25. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population./Yamamoto T., Iwase A., Araie M., Suzuki Y., Abe H., Shirato S., et al.//Ophthalmology. - 2001 - Vol. 112. - P. 1661 - 1669.

26. Glaucoma in China: how big is the problem?/Foster P.J., Jonson G.J.//Br J Ophthalmol. - 2001 - Vol. 85. - P. 1277 - 82.

27. Primary angle closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population./Alsbirk P.H.//Acta Ophthalmol. - 1976 - Vol. 54. - P. 531.

28. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok./Bourne R.A., Sukudom P., Foster P.J., Tantisevi V., Jitapunkul S., Lee P.S., et al.//Br J Ophthalmol. - 2003 - Vol. 87. - P. 1069 - 1074.

29. The definition and classification of glaucoma in prevalence surveys./Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J.//Br J Ophthalmol. - 2002 - Vol. 86(2). - P. 238 - 42.

30. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review./Day A.C., Baio G., Gazzard G., et al.//Br J Ophthalmol. - 2012 - 96(9). - P. 1162 - 7.

31. Общая заболеваемость взрослого населения России в 2018 году: Статистические материалы. Часть IV. М., 2019 - С. 45 - 46. URL: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-informatsionnye-materialy/statisticheskiy-sbornik-2018-god.

32. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry/Morales J., Weitzman M.L., Gonzalez de la Rosa M.//Ophthalmology - 2000 - Vol. 107, N 1 - P. 134 - 42.

33. Combining structural and functional testing for detection of glaucoma/Shah N.N., Bowd C., Medeiros F.A., et al.//Ophthalmology - 2006 - Vol. 113, N 9 - P. 1593 - 602.

34. Levels of diagnostic studies. In Weinreb R.N., Greve E.L. (Eds.), Glaucoma diagnosis: Structure and Function. Consensus series I./Coleman A., Friedman D., Gandolfi S., Singh K., Tuulonen A.//Amsterdam: Kugler Puplications - 2004 - P. 9 - 12.

35. Early detection of primary angle-closure glaucoma. Limbal and axial chamber depth screening in a high risk population (Greenland Eskimos)./Alsbirk P.H.//Acta Ophthalmol. - 1988 - Vol. 66. - P. 556 - 564.

36. Followup of angle-closure glaucoma suspects./Wilensky J.T., Kaufman P.L., Frohlichstein D., Gieser D.K., Kass M.A., Ritch R., et al.//Am J Ophthalmol. - 1993 - Vol. 115. - P. 338 - 346.

37. Anatomical risk factors in primary angle-closure glaucoma. A ten-year follow- up survey based on limbal and axial anterior chamber depths in a high risk population./Alsbirk P.H. Int Ophthalmol. - 1992 - Vol. 16. - P. 265 - 272.

38. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study./Thomas R., George R., Parikh R., et al.//Br J Ophthalmol. - 2003 - Vol. 87. - P. 450 - 454.

39. The heritability and sibling risk of angle closure in Asians./Amerasinghe N., Zhang J., Thalamuthu A., et al.//Ophthalmology. - 2011 - Vol. 118. - P. 480 - 5.

40. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma./Lowe R.F.//Br J Ophthalmol. - 1970 - Vol. 54. - P. 161 - 169.

41. Screening techniques for angleclosure glaucoma in rural Taiwan./Congdon N.G., Quigley H.A., Hung P.T., Wang T.H., Ho T.C.//Acta Ophthalmol. - 1996 - Vol. 74. - P. 113 - 119.

42. Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore./Wong T.Y., Foster P.J., Seah S.K., Chew P.T.//Br J Ophthalmol. - 2000 - Vol. 84. - P. 990 - 992.

43. Predisposing factors for chronic angle-closure glaucoma./Salmon J.F.//Prog Retin Eye Res. - 1999 - Vol. 18. - P. 121 - 32.

44. Acute angle-closure glaucoma. The second eye: an analysis of 200 cases./Lowe R.F. Br J Ophthalmol. - 1962 - Vol. 46. - P. 641 - 50.

45. Pharmacological and environmental factors in primary angle-closure glaucoma. Subak-Sharpe I., Low S., Nolan W., Foster P.J.//Br Med Bull. - 2010 - Vol. 93. - P. 125 - 43.

46. Influence of family history as a risk factor on primary angle closure and primary open angle glaucoma in a Chinese population./Kong X., Chen Y., Chen X., Sun X.//Ophthalmic Epidemiol. - 2011 - Vol. 18. - P. 226 - 32.

47. Drug-induced acute angle closure glaucoma./Lachkar Y., Bouassida W.//Curr. Opin. Ophthalmol. - 2007. - Vol. 18(2). - P. 129 - 33.

48. Drug-induced ocular disorders./Li J., Tripathi R.C., Tripathi B.J.//Drug Saf. - 2008 - Vol. 31. - P. 127 - 41.

49. Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos./Wojciechowski R., Congdon N., Anninger W., Teo Broman A.//Ophthalmology. - 2003 - Vol. 110. - P. 365 - 75.

50. Plateau iris in Asian subjects with primary angle closure glaucoma./Kumar R.S., Tantisevi V., Wong M.H., et al.//Arch Ophthalmol. - 2009 - Vol. 127. - P. 1269 - 72.

51. Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle./Van Herick W., Shaffer R.N., Schwartz A.//Am J Ophthalmol. - 1969 - Vol. 68. - P. 626 - 9.

52. Screening for narrow angles in the Singapore population: evaluation of new noncontact screening methods./Lavanya R., Foster P.J., Sakata L.M., et al.//Ophthalmology. - 2008 - Vol. 115. - P. 1720 - 7.

53. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial/Bengtsson B., Leske M.C., Hyman L., Heijl A.//Ophthalmology - 2007 - Vol. 114, N 2 - P. 205 - 9.

54. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study/Caprioli J., Coleman A.L.//Ophthalmology - 2008 - Vol. 115, N 7 - P. 1123 - 9.

55. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension/Bengtsson B., Heijl A.//Graefes Arch. Clin. Exp. Ophthalmol - 2005 - Vol. 243, N 6 - P. 513 - 8.

56. Predictors of long-term progression in the early manifest glaucoma trial/Leske MC, Heijl A, Hyman L, et al.//Ophthalmology - 2007 - Vol. 114, N 11 - P. 1965 - 72.

57. The flashlight test and Van Herick's test are poor predictors for occludable angles./Thomas R., George T., Braganza A., Muliyil J.//Aust N Z J Ophthalmol. - 1996 - Vol. 24. - P. 251 - 256.

58. Detection of gonioscopically occludable angles and primary angle-closure glaucoma by estimation of limbal chamber depth in Asians: Modified grading scheme./Foster P.J., Devereux J., Alsbirk P.H., et al.//Br J Ophthalmol. - 2000 - Vol. 84. - P. 186 - 192.

59. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population./Devereux JG, Foster PJ, Baasanhu J, Uranchimeg D, Lee PS, Erdenbeleig T, Machin D, Johnson G.J., Alsbirk P.H.//Arch Ophthalmol. - 2000 - Vol. 118. - P. 257 - 263.

60. The normal development of the human anterior chamber angle: a new system of descriptive grading/Spaeth G.L.//Trans. Ophthalmol. Soc. UK - 1971 - Vol. 91 - P. 709 - 39.

61. Gonioscopy anatomy of the angle of the anterior chamber of the eye. In. SRe, ed. In: Stereoscopic manual of gonioscopy/Shaffer R.N.//St. Louis, Mosby - 1962.

62. In: Lehrbuch der klinischen Ophthalmologie/Kanski J.S., M. Glaukom. In: Kanski J. SMe, ed.//Stuttgart, New York Thieme - 1987.

63. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern(R) Guidelines. Primary Open-Angle Glaucoma. San Francisco, CA: American Academy of Ophthalmology, 2015. 111 p.

64. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology/Lin S.C., Singh K., Jampel H.D. et al.//Ophthalmology - 2007 - Vol. 114 - P. 1937 - 49.

65. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study/Keltner J.L., Johnson C.A., Levine R.A., et al.//Arch. Ophthalmol - 2005 - Vol. 123 - P. 1201 - 6.

66. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography/Chauhan B.C., McCormick T.A., Nicolela M.T., LeBlanc R.P.//Arch Ophthalmol - 2001 - Vol. 119 - P. 1492 - 9.

67. Results of the European Glaucoma Prevention Study/Miglior S., Zeyen T., Pfeiffer N., et al, European Glaucoma Prevention Study (EGPS) Group.//Ophthalmology - 2005 - Vol. 112 - P. 366 - 75.

68. Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic./Aghaian E., Choe J.E., Lin S., Stamper R.L.//Ophthalmology. - 2004 - Vol. 111. - P. 2211 - 9.

69. Commingling analyses of central corneal thickness and adjusted intraocular pressure in an older Australian population/Rahman M.L., Bunce C., Healey P.R., et al.//Invest. Ophthalmol. Vis. Sci. - 2010 - Vol. 51, N 5 - P. 2512 - 8.

70. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology/Dueker D.K., Singh K., Lin S.C., et al.//Ophthalmology. - 2007 - N 114 - P. 1779 - 87.

71. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy/Medeiros F.A., Sample P.A., Zangwill L.M., et al.//Am. J. Ophthalmol. - 2003 - N 136 - P. 805 - 13.

72. Imaging of the optic nerve and retinal nerve fiber layer: an essential part of glaucoma diagnosis and monitoring/Kotowski J., Wollstein G., Ishikawa H., Schuman J.S.//Surv. Ophthalmol - 2014 - Vol. 59 - P. 458 - 67.

73. Diagnosing glaucoma progression with optical coherence tomography/Leung CK.//Curr. Opin. Ophthalmol - 2014 - Vol. 25 - P. 104 - 11.

74. Results of the European Glaucoma Prevention Study/Miglior S., Zeyen T., Pfeiffer N., et al, European Glaucoma Prevention Study (EGPS) Group.//Ophthalmology - 2005 - Vol. 112 - P. 366 - 75.

75. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects/Lalezary M., Medeiros F.A., Weinreb R.N., et al.//Am. J. Ophthalmol - 2006 - Vol. 142 - P. 576 - 82.

76. Anterior chamber angle assessment techniques./Friedman D.S., He M.//Surv Ophthalmol. - 2008 - Vol. 53. - P. 250 - 73.

77. Anterior chamber depth in Mongolians. Variation with age, sex and method of measurement./Foster P.J., Alsbirk P.H., Baahanhu J., et al.//Am J Ophthalmology. - 1997 - Vol. 124. P. 53 - 60.

78. Evaluation of the anterior chamber angle in Asian Indian eyes by ultrasound biomicroscopy and gonioscopy./Kaushik S., Jain R., Pandav S.S., Gupta A.//Indian J Ophthalmol. - 2006 - Vol. 54. - P. 159 - 63.

79. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes./Nolan W.P., See J.L., Chew P.T., et al.//Ophthalmology. - 2007 - Vol. 114. - P. 33 - 9.

80. High-definition optical coherence tomography imaging of the iridocorneal angle of the eye./Wong H.T., Lim M.C., Sakata L.M., et al.//Arch Ophthalmol. 2009 - Vol. 127. - P. 256 - 60.

81. Assessment of circumferential angle-closure by the iris-trabecular contact index with swept-source optical coherence tomography./Baskaran M., Ho S.W., Tun T.A., et al.//Ophthalmology. - 2013 - Vol. 120. - P. 2226 - 31.

82. Guidelines for Glaucoma Eye Care. International Council of Ophthalmology. San Francisco, California. 2015 - 20 p.

83. Pilocarpine induces an increase in the anterior chamber angular width in eyes with narrow angles./Kobayashi H., Kobayashi K., Kiryu J., Kondo T.//Br J Ophthalmol. - 1999 - Vol. 83. - P. 553 - 558.

84. World Glaucoma Association Consensus Statement: Medical Treatment of Glaucoma The Netherlands: Kluger - 2010 - 310 p.

85. Pilocarpine induced acute angle closure./Day A., Nolan W., Malik A., Viswanathan A., Foster P.//BMJ Case Rep. - 2012 - Vol. 8 - P. 56.

86. Outcomes of different management options for malignant glaucoma: a retrospective study./Debrouwere V., Stalmans P., Van Calster J. et al.//Graefes. Arch. Clin. Exp. Ophthalmol. - 2012 - Vol. 250 (1). - P. 131 - 141.

87. An Overview of Treatment Methods for Primary Angle Closure./Anwar F., Turalba A.//Semin Ophthalmol. - 2017 - Vol. 32(1). - P. 82 - 85.

88. Pharmacological therapy for glaucoma: a review./Hoyng P.F., van Beek L.M.//Drugs. - 2000 - Vol. 59(3). - P. 411 - 34.

89. Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years./Ramani K.K., Mani B., George R.J., Lingam V.//J Glaucoma. - 2009. - Vol. 18. - P. 521 - 7.

90. Ocular symptoms and signs with preserved and preservative free glaucoma medications/Jaenen N., Baudouin C., Pouliquen P., et al.//Eur. J, Ophthalmol - 2007 - Vol. 17, N 3 - P. 341 - 9.

91. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review/Olthoft C.M., Schuten J.S., Van de Borne B.W., Webers C.A.//Ophthalmology - 2005 - Vol. 112, N 6 - P. 953 - 61.

92. Compliance in patients prescribed eye drops for glaucoma/Patel S.C., Spaeth G.L.//Ophthalmic Surg - 1995 - Vol. 26, N 3 - P. 953 - 61.

93. The effect of Varying Dosing Interval on the Efficacy of Intraocular Pressure Lowering Drugs/Serle J.B., Toor A., Fahim M.M., et al.//Invest. Ophthalmol. Vis. Sci. - 2004 - Vol. 45, N 5 - P. 97.

94. Considerations in glaucoma therapy: fixed combinations versus their component medications/Higginbotham E.J.//Clin. Ophthalmol - 2010 - N 4 - P. 1 - 9.

95. Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review/Cox J.A., Mollan S.P., Bankart J., Robinson R.//Br. J. Ophthalmol - 2008 - Vol. 92, N 6 - P. 729 - 34.

96. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication/Pisella P.J., Pouliquen P., Baudouin C.//Br. J. Ophthalmol - 2002 - Vol. 86, N 4 - P. 418 - 23.

97. Glaucoma management in pregnancy: a questionnaire survey/Vaideanu D., Fraser S.//Eye (Lond) - 2007 - N 21 - P. 341 - 343.

98. Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure/Madadi P., Koren G., Freeman D.J., et al.//J. Glaucoma - 2008 - N 17 - P. 329 - 331.

99. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study/Ho J.D., Hu C.C., Lin H.C.//Br. J. Ophthalmol - 2009 - N 10 - P. 1283 - 1286.

100. Acute angle closure glaucoma: acetazolamide therapy./Lowe R.F.//Austral J Ophthalmol. - 1973 - Vol. 1 - P. 24.

101. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment./Choong Y.F., Irfan S., Menage M.J.//Eye (Lond). - 1999 - Vol. 13 (Pt 5). - P. 613 - 6.

102. Efficacy of medical therapy in the initial management of acute primary angle closure in Asians./Ramli N., Chai S.M., Tan G.S., Husain R., Hoh S.T., Ho C.L., Aung T.//Eye (Lond). - 2010 - Vol. 24(10). - P. 1599 - 602.

103. Acute primary angle closure-treatment strategies, evidences and economical considerations./Chan P.P., Pang J.C., Tham C.C.//Eye (Lond). - 2019 - Vol. 33(1). - P. 110 - 119.

104. Corneal indentation to relieve acute angle-closure glaucoma./Anderson D.R.//Am J Ophthalmol. - 1979 - Vol. 88. - P. 1091 - 3.

105. Malignant glaucoma and its management./Ruben S., Tsai J., Hitchings R.//Brit. J. Ophthamol - 1997 - Vol. 81. - P. 163 - 167.

106. Treatment course of recurrent malignant glaucoma monitoring by ultrasound biomicroscopy: a report of two cases./Shen C.J., Chen Y.Y., Sheu S.J.//Kaohsiung J Med Sci. - 2008 - Vol. 24(11). - P. 608 - 13.

107. Clinical evidence for neuroprotection in glaucoma/Cordeiro M.F., Levin L.A.//Am. J. Ophthalmol - 2011 - Vol. 152, N 5 - P. 715 - 6.

108. Neuroprotection for treatment of glaucoma in adults/Sena D.F., Lindsley K.//Cochrane Database Syst Rev - 2013 - N 2: CD006539.

109. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study/Krupin T., Liebmann J.M., Greenfield D.S., et al.//Am. J. Ophthalmol. - 2011 - Vol. 151, N 4 - P. 671 - 81.

110. Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology./Radhakrishnan S., Chen P.P., Junk A.K., Nouri-Mahdavi K., Chen T.C.//Ophthalmology. - 2018. - Vol. 125(7). - P. 1110 - 1120.

111. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial./He M., Jiang Y., Huang S., et al.//Lancet. - 2019 - Vol. 393. - P. 1609 - 18.

112. Design and methodology of a randomized controlled trial of laser iridotomy for the prevention of angle closure in southern China: the Zhongshan Angle Closure Prevention trial./Jiang Y., Friedman D.S., He M., et al.//Ophthalmic Epidemiol. - 2010 - Vol. 17. - P. 321 - 32.

113. Functional evaluation of an ridotomy in primary angle closure eyes./Sihota R., Rishi K., Srinivasan G., Gupta V., Dada T., Singh K.//Graefes Arch Clin Exp Ophthalmol. - 2016 - Vol. 254(6). - P. 1141 - 9.

114. Comparison of ultrasound biomicroscopic parameters after laser iridotomy in eyes with primary angle closure and primary angle closure glaucoma./Dada T., Mohan S., Sihota R., et al.//Eye (Lond). - 2007 - Vol. 21. - P. 956 - 61.

115. Long-term progression after laser peripheral iridotomy in Caucasian primary angle closure suspects./Pearce F.C., Thomas R., Wong N.J., Walland M.J.//Clin Exp Ophthalmol. - 2018 - Vol. 46(7). - P. 828 - 830.

116. Randomised controlled trial of screening and prophylactic treatment to prevent primary angle closure glaucoma./Yip J.L., Foster P.J., Uranchimeg D., et al.//Br J Ophthalmol. - 2010 - Vol. 94. - P. 1472 - 7.

117. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy./Yuen N.S., Cheung P., Hui S.P.//Jpn J Ophthalmol. - 2005 - Vol. 49(2). - P. 89 - 92.

118. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures./Chevrier R.L., Assalian A., J., Lesk M.R.//Ophthalmic Surg Lasers. - 1999 - Vol. 30(3). - P. 199 - 204.

119. Lasers IN PRIMARY ANGLE CLOSURE./W. K. Chee, S. Srinivasan, J. Cheng.//US Ophthalmic Review. - 2015 - Vol. 8(2). - P. 99 - 102.

120. Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects./Jiang Y., Chang D.S., Foster P.J., He M., Huang S., Aung T., Friedman D.S.//Ophthalmology. - 2012 - Vol. 119(2). - P. 283 - 8.

121. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery/Chen T.C.//J. Cataract. Refract. Surg. - 2005 - Vol. 31. - P. 1707 - 12.

122. YAG laser iridotomy treatment for primary angle-closure in East Asian eyes./Nolan W.P., Foster P.J., Devereux J.G., et al.//Br J Ophthalmol. - 2000 - Vol. 84. - P. 1255 - 1259.

123. Laser iridotomy in dark irides./de Silva D.J., Gazzard G., Foster P. Br J Ophthalmol. - 2007 - Vol. 91(2). - P. 222 - 5.

124. Argon laser peripheral iridoplasty and laser iridoectomy for plateau iris glaucoma./Peng D., Zhang X., Yu K.//Zhonghua Yan Ke Za Zhi. - 1997 - Vol. 33. - P. 165 - 168.

125. Laser surgery for angle closure glaucoma./Liebmann J.M., Ritch R.//Semin Ophthalmol. - 2002 - Vol. 17(2). - P. 84 - 91.

126. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial./Narayanaswamy A., Leung C.K., Istiantoro D.V., Perera S.A., Ho C.L., Nongpiur M.E., Baskaran M., Htoon H.M., Wong T.T., Goh D., Su D.H., Belkin M., Aung T.//JAMA Ophthalmol. - 2015 - Vol. 133(2). - P. 206 - 12.

127. Selective Laser Trabeculoplasty in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy: A Case-Control Study./Ali Aljasim L., Owaidhah O., Edward D.P.//J Glaucoma. - 2016 - Vol. 25(3). - P. 253 - 8.

128. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%/Barnes S.D., Campagna J.A., Dirks M.S., Doe E.A.//Ophthalmology - 1999 - N 106 - P. 2033 - 7.

129. Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options/Dastiridou A., Katsanos A., Denis P., Francis B., Mikropoulos D., Teus M, Konstas A.//Adv. Ther. - 2018 - Vol. 35, N 12 - P. 2103 - 2127.

130. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma/Murphy C.C., Burnett C.A., Spry P.G., et al.//Br. J. Ophthalmol - 2003 - Vol. 87, N 10 - P. 1252 - 7.

131. Cyclodestructive procedures for refractory glaucoma/Chen M.F., Kim C.H., Coleman A.L.//Cochrane Database Syst Rev. - 2019 - N 10 - 3: CD012223.

132. Cyclophotocoagulation in Glaucoma Management./Stanley J. Berke//Endolaser Techniques in Opthalmology. - 2006 - Vol. 4(2). - P. 74 - 81.

133. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma./Tan A.M., Chockalingam M., Aquino M.C., Lim Z.I., See J.L., Chew P.T.//Clin Exp Ophthalmol. - 2010 - Vol. 38(3). - P. 266 - 72.

134. Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population./Sihota R., Gupta V., Agarwal H.C.//Clin Exp Ophthalmol. - 2004 - Vol. 32. - P. 23 - 28.

135. Trabeculectomy in patients with primary angle-closure glaucoma./Chen Y.H., Lu D.W., Cheng J.H., et al.//J Glaucoma. - 2009 - Vol. 18. - P. 679 - 83.

136. Trabeculectomy for acute primary angle closure./Aung T., Tow S.L., Yap E.Y., et al.//Ophthalmology. - 2000 - Vol. 107. - P. 1298 - 302.

137. The Moorfields safer surgery system. Middle East Afr./Dhingra S., Khaw P.T.//J. Ophthalmol - 2009 - Vol. 16 - P. 112 - 5.

138. Long-term outcomes of needle revision of failing deep sclerectomy blebs/Koukkoulli A., Musa F., Anand N.//Graefes Arch. Clin. Exp. Ophthalmol - 2015 - Vol. 253, N 1 - P. 99 - 106.

139. Needling revision of trabeculectomies bleb morphology and long-term survival/Rotchford A.P., King A.J.//Ophthalmology - 2008 - Vol. 115 - P. 1148 - 53.

140. 5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study/Goldenfeld M, Krupin T, Ruderman J.M., et al.//Ophthalmology - 1994 - Vol. 101 - P. 1024 - 9.

141. Single intraoperative application of 5-Fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial/Leyland M., Bloom P., Zinicola E., et al.//J. Glaucoma - 2001 - Vol. 10 - P. 452 - 7.

142. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure./Lam D.S., Leung D.Y., Tham C.C., et al.//Ophthalmology. - 2008 - Vol. 115. - P. 1134 - 40.

143. Clinical outcomes after lens extraction for visually significant cataract in eyes with primary angle closure./Shams P.N., Foster P.J.//J Glaucoma. - 2012. - Vol. 21. - P. 545 - 50.

144. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy./Husain R., Gazzard G., Aung T., et al.//Ophthalmology. - 2012 - Vol. 119. - P. 2274 - 81.

145. Effectiveness in Angle-closure Glaucoma of Lens Extraction (EAGLE) Study Group. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial./Azuara-Blanco A., Burr J.M., Cochran C., et al//Trial. - 2011 - Vol. 12 P. 133.

146. Phacoemulsification and intraocular lens implantation in nanophthalmic eyes. Report of a medium-size series./Faucher A., Hasanee K., Rootman D.S.//J Cataract Refract Surg. - 2002 - Vol. 28. - P. 837 - 842.

147. Primary phacoemulsification for uncontrolled angle-closure glaucoma./Roberts T.V., Francis I.C., Lertusumitkul S., et al.//J Cataract Refract Surg. - 2000 - Vol. 26. - P. 1012 - 1016.

148. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma./Hayashi K., Hayashi H., Nakao F., Hayashi F.//Ophthalmology. - 2000 - Vol. 107. - P. 698 - 703.

149. Phacotrabeculectomy in treatment of primary angleclosure glaucoma and primary open-angle glaucoma./Lai J.S., Tham C.C., Chan J.C., Lam D.S.//Jpn J Ophthalmol. - 2004 - Vol. 48. - P. 408 - 411.

150. Combined phacoemulsification, intraocular lens implantation and trabeculectomy in Asian patients with chronic angle closure glaucoma./Tow S.L.C, Aung T., Oen F.T.S., Seah S.K.L.//Int Ophthalmol. - 2001 - Vol. 24. - P. 283 - 289.

151. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts./Tham C.C., Kwong Y.Y., Leung D.Y., et al.//Ophthalmology. - 2009 - Vol. 116. - P. 725 - 31.

152. Cataract surgery and its effect on intraocular pressure./Obstbaum S.A.//J Cataract Refract Surg. - 1999 - Vol. 25. - P. 877.

153. Lens extraction for uncontrolled glaucoma./Gunning F.P., Greve E.L.//J Cataract Refract Surg. - 1998 - Vol. 24. - P. 1347 - 1356.

154. Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes./Hansapinyo L., Choy B.N.K., Lai J.S.M., Tham C.C.//J Glaucoma. - 2020 - Vol. 29(1). - P. 15 - 23.

155. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes./Sharma A., Sii F., Shah P., Kirkby G.R.//Ophthalmology. - 2006 - Vol. 113. - P. 1968 - 1973.

156. Malignant glaucoma (aqueous misdirection) after pars plana vitrectomy./Francis B.A., Babel D.//Ophthalmology. - 2000 - Vol. 107. - P. 1220 - 1222.

157. Glaucoma surgery: Treatment and Techniques/Eds. Carreti L., Burrato L. Milan: Springer; 2018: 132

158. Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma and cataract./Chung A.N., Aung T., Wang J.C., Chew P.T.K.//Am J Ophthalmol. - 2004 - Vol. 137. - P. 294 - 300.

159. Present and New Treatment Strategies in the Management of Glaucoma./Kolko M. Open Ophthalmol J. 2015; 9: 89 - 100.

160. Protection of retinal ganglion cells in glaucoma: Current status and future./Shen J., Wang Y., Yao K. Exp Eye Res. 2021; 205: 108506.

161. Исследование лиганд-рецепторного взаимодействия и биораспределения при различных режимах введения лекарственного средства, содержащего полипептиды сетчатки глаз скота./Верлов Н.А., Доротенко А.Р., Гулина А.С. и др. Вестник офтальмологии. 2021; 137(5): 88 - 95.

162. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina./Romano C., Price M.T., Almli T., Olney J.W. Invest Ophthalmol Vis Sci. 1998; 39(2): 416 - 423.

163. Метаанализ рандомизированных клинических исследований эффективности и безопасности нейропротекторной терапии глаукомы с использованием комплекса водорастворимых полипептидных фракций./Еричев В.П., Петров С.Ю., Волжанин А.В. Национальный журнал Глаукома. 2016; 15(4): 71 - 81.

164. Ретинопротекция как терапевтическая стратегия глаукомы: обзор исторических и современных мировых тенденций./Лоскутов И.А., Саверская Е.Н., Лоскутова Е.И. Национальный журнал Глаукома. 2017; 16(4): 86 - 97.

165. Еричев В.П., Петров С.Ю., Волжанин А.В. Метаанализ рандомизированных клинических исследований эффективности и безопасности нейропротекторной терапии глаукомы с использованием комплекса водорастворимых полипептидных фракций. Национальный журнал Глаукома. 2016; 15(4): 71 - 81

166. Егоров Е.А., Гветадзе А.А., Давыдова Н.Г. Антиоксидантный препарат в нейропротективной терапии при глаукоме//Вестник офтальмологии, N 2, 2013, стр. 67 - 69

167. Мовсисян А.Б., Оганезова Ж.Г., Егоров Е.А. Возможности и результаты применения антиоксидантной терапии в офтальмологической практике. Вестник офтальмологии. 2022; 138(5): 122 - 128. https://doi.org/10.17116/oftalma2022138051122.

168. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: an evidence-based review/Jampel H.D., Friedman D.S., Lubomski L.H., et al.//Ophthalmology - 2002 - N 109 - P. 2215 - 24.

169. Factors predicting the success of trabeculectomy bleb enhancement with needling/Than J.Y.L., Al-Mugheiry T.S., Gale J., Martin K.R.//Br. J. Ophthalmol - 2018 - Vol. 102, N 12 - P. 1667 - 1671.

170. Ocular digital massage for the management of post-trabeculectomy underfiltering blebs/Ali M, Akhtar F.//J. Coll. Physicians Surg. Pak - 2011 - Vol. 21, N 11 - P. 676 - 9.

171. Economic considerations of the diagnosis and management for glaucoma in the developed world/Tuulonen A.//Curr. Opin. Ophthalmol - 2011 - Vol. 22, N 2 - P. 102 - 9.

172. Screening for Glaucoma: Comparative Effectiveness/Ervin A.M., Boland M.V., Myrowitz E.H., et al.//Rockville (MD) - 2012. 12-EHC037-EF.

173. Tunnel vision: the economic impact of primary open angle glaucoma - a dynamic economic model./Taylor H.R., Crowston J., Keeffe J., et al.//Melbourne: Centre for Eye Research Australia, 2008. www.cera.org.au.

174. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy./Ang L.P., Aung T., Chew P.T.//Ophthalmology. - 2000 - Vol. 107. - P. 2092 - 6.

175. Behaviour of the fellow eye in acute angle-closure glaucoma./Edwards R.S.//Br J Ophthalmol. - 1982 - Vol. 66. - P. 576 - 9.

176. Follow-up of angle-closure glaucoma suspects./Wilensky J.T., Kaufman P.L., Frohlichstein D., et al.//Am J Ophthalmol. - 1993 - Vol. 115. - P. 338 - 46.

177. Interventions for angle-closure glaucoma: an evidence-based update./Saw S.M., Gazzard G., Friedman D.S.//Ophthalmology. - 2003 - Vol. 110. - P. 1869 - 78.

178. Value of prophylactic peripheral iridectomy on the second eye in angle-closure glaucoma./Snow J.T.//Trans Ophthalmol Soc U K. - 1977 - Vol. 97. - P. 189 - 91.